Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Interest-Expense" stands at 1.18 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 03/31/2024.
Merck & Company Inc's third quarter result of 0.238 Billion USD for the item "Interest Expense" represents a decrease of -21.97 percent compared to it's second quarter result.
Also, Merck & Company Inc's third quarter result of 0.238 Billion USD for the item "Interest Expense" represents a decrease of -27.88 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 1.18 Billion USD for the item "Interest Expense" represents a decrease of -7.21 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -5.51 percent compared to the value the year prior.
The 1 year change in percent is -5.51.
The 3 year change in percent is 26.50.
The 5 year change in percent is 40.45.
The 10 year change in percent is 77.25.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Interest Expense | 905,699,262,464.00 |
![]() | Johnson & Johnson - Interest Expense | 486,508,953,600.00 |
![]() | AbbVie Inc - Interest Expense | 399,570,305,024.00 |
![]() | Roche Holding AG - Interest Expense | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Interest Expense | 280,205,508,085.11 |